Compare Rigetti Computing Inc (RGTI) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rigetti Computing Inc vs Smith & Nephew plc — how do they compare? Rigetti Computing Inc trades at $14.03 (market cap $4.72B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Smith & Nephew plc is far larger — about 2.4× Rigetti Computing Inc's market cap, and Smith & Nephew plc pays a 2.95% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rigetti Computing Inc for 35 Days and Smith & Nephew plc for 121 Days on average.
| RGTI | SNN | |
|---|---|---|
Market Cap | $4.72B | $11.10B |
Volume | 17,136,381 | 1,051,703 |
Sector | Technology | Health |
52-Week High | $56.34 | $37.17 |
52-Week Low | $12.90 | $26.42 |
Typical Hold Time | 35 Days | 121 Days |
Enterprise Value | $4.33B | $14.13B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGTI trades at $14.14, down 3.08% today, amid bearish technical signals despite bullish oscillators. The company shows negative profitability with a -1,787.4% net income margin and -$216.21M net loss for 2025, though revenue grew to $13M in 2026. Recent news highlights Rigetti's hybrid quantum-HPC strategy advancements and sector momentum from IonQ's developments.
Wall Street maintains strong bullish sentiment with 6 buy ratings and a $21.67 price target, representing 53% upside. However, significant execution risks persist given negative cash flow, high valuation multiples, and intense quantum computing competition. The stock offers high-risk growth potential for investors comfortable with speculative emerging technology plays.
SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.
The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
